Analyst Ratings For Aquestive Therapeutics Inc (NASDAQ:AQST)

Today, JMP Securities initiated coverage on Aquestive Therapeutics Inc (NASDAQ:AQST) with a Outperform.

There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Aquestive Therapeutics Inc (NASDAQ:AQST) is Buy with a consensus target price of N/A per share, a potential N/A.

Some recent analyst ratings include

• 8/20/2018-Aquestive Therapeutics Inc (NASDAQ:AQST) has coverage initiated with a Outperform rating
• 8/20/2018-Aquestive Therapeutics Inc (NASDAQ:AQST) has coverage initiated with a Outperform rating

Recent Trading Activity for Aquestive Therapeutics Inc (NASDAQ:AQST)
Shares of Aquestive Therapeutics Inc closed the previous trading session at 16,00 −0,10 0,62 % with 53086 shares trading hands.